Effectiveness of Medication Based Treatment for Opioid Use Disorder

Gowthami Bainaboina
{"title":"Effectiveness of Medication Based Treatment for Opioid Use Disorder","authors":"Gowthami Bainaboina","doi":"10.36648/1479-1072.29.2.18","DOIUrl":null,"url":null,"abstract":"Many people with OUD enjoy treatment with medication for variable lengths of your time, together with womb-to-tomb treatment. in progress patient medication treatment for OUD is joined to higher retention and outcomes than treatment while not medication. Even so, some folks stop exploitation opioids on their own; others recover through support teams or specialty patient or residential treatment with or while not medication. Still, FDA-approved medication ought to be thought of and offered to patients with OUD as a part of their treatment. Benefits • The 3 FDA-approved medications accustomed treat OUD improve patients’ health and health by: • Reducing or eliminating withdrawal symptoms: synthetic heroin, buprenorphine. •Blunting or obstruction the consequences of illicit opioids: synthetic heroin, naltrexone, buprenorphine. •Reducing or eliminating cravings to use opioids: synthetic heroin, naltrexone, buprenorphine. Studies show that individuals with opioid use disorder UN agency follow detoxification with complete abstinence area unit terribly possible to relapse, or come to exploitation the drug. whereas relapse could be a traditional tread the trail to recovery, it may be life threatening, raising the danger for a fatal dose [1]. Thus, a crucial thanks to support recovery from diacetylmorphine or prescription opioid use disorder is to take care of abstinence from those medication. Somebody in recovery may use medications that scale back the negative effects of withdrawal and cravings while not manufacturing the high spirits that the first drug of abuse caused. as an example, the federal agency recently approved lofexidine, a non-opioid medication designed to cut back opioid withdrawal symptoms. synthetic heroin and buprenorphine area unit different medications approved for this purpose","PeriodicalId":88096,"journal":{"name":"Quality in primary care","volume":"76 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quality in primary care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36648/1479-1072.29.2.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Many people with OUD enjoy treatment with medication for variable lengths of your time, together with womb-to-tomb treatment. in progress patient medication treatment for OUD is joined to higher retention and outcomes than treatment while not medication. Even so, some folks stop exploitation opioids on their own; others recover through support teams or specialty patient or residential treatment with or while not medication. Still, FDA-approved medication ought to be thought of and offered to patients with OUD as a part of their treatment. Benefits • The 3 FDA-approved medications accustomed treat OUD improve patients’ health and health by: • Reducing or eliminating withdrawal symptoms: synthetic heroin, buprenorphine. •Blunting or obstruction the consequences of illicit opioids: synthetic heroin, naltrexone, buprenorphine. •Reducing or eliminating cravings to use opioids: synthetic heroin, naltrexone, buprenorphine. Studies show that individuals with opioid use disorder UN agency follow detoxification with complete abstinence area unit terribly possible to relapse, or come to exploitation the drug. whereas relapse could be a traditional tread the trail to recovery, it may be life threatening, raising the danger for a fatal dose [1]. Thus, a crucial thanks to support recovery from diacetylmorphine or prescription opioid use disorder is to take care of abstinence from those medication. Somebody in recovery may use medications that scale back the negative effects of withdrawal and cravings while not manufacturing the high spirits that the first drug of abuse caused. as an example, the federal agency recently approved lofexidine, a non-opioid medication designed to cut back opioid withdrawal symptoms. synthetic heroin and buprenorphine area unit different medications approved for this purpose
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿片类药物使用障碍药物治疗的有效性
许多患有OUD的人享受不同时间长度的药物治疗,以及从子宫到坟墓的治疗。正在进行的OUD患者药物治疗与不药物治疗相比具有更高的保留率和预后。即便如此,一些人自己停止了对阿片类药物的利用;其他人则通过支持团队或专科患者或住院治疗(或不服药)康复。尽管如此,fda批准的药物应该被考虑并提供给OUD患者作为他们治疗的一部分。•fda批准的用于治疗OUD的3种药物通过以下方式改善患者的健康:•减少或消除戒断症状:合成海洛因,丁丙诺啡。•减弱或阻碍非法阿片类药物的后果:合成海洛因、纳曲酮、丁丙诺啡。•减少或消除对阿片类药物的渴望:合成海洛因、纳曲酮、丁丙诺啡。研究表明,患有阿片类药物使用障碍的人在戒毒后完全戒断,极有可能复发,或来利用药物。虽然复发可能是通往康复的传统道路,但它可能危及生命,增加致命剂量的危险[1]。因此,支持从二乙酰吗啡或处方阿片类药物使用障碍中恢复的一个关键感谢是注意戒断这些药物。恢复期的一些人可能会使用药物来减少戒断和渴望的负面影响,同时又不会像第一次滥用药物那样产生高昂的情绪。例如,联邦机构最近批准了洛非昔定,一种旨在减少阿片类药物戒断症状的非阿片类药物。合成海洛因和丁丙诺啡是被批准用于此目的的不同药物
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluating improvement. Understanding processes and how to improve them. Commissioning for quality improvement. The Impact 0f Pandemic Ebola Virus 0n Global Public Health Preterm birth and factors: An institution based cross-sectional study in case of southern Ethiopia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1